VanEck Associates’s Sharps Compliance Corp SMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-221,313
Closed -$1.58M 1420
2021
Q4
$1.58M Buy
221,313
+65,391
+42% +$502K ﹤0.01% 764
2021
Q3
$1.29M Buy
155,922
+44,668
+40% +$415K ﹤0.01% 769
2021
Q2
$1.15M Buy
111,254
+45,131
+68% +$628K ﹤0.01% 780
2021
Q1
$950K Sell
66,123
-14,028
-18% -$181K ﹤0.01% 750
2020
Q4
$757K Sell
80,151
-7,561
-9% -$57.8K ﹤0.01% 716
2020
Q3
$550K Buy
87,712
+1,367
+2% +$9.94K ﹤0.01% 734
2020
Q2
$607K Buy
+86,345
New +$614K ﹤0.01% 701

Other funds holding SMED

VanEck Associates's SMED Position: Q1 2022 in Review

VanEck Associates sold out of Sharps Compliance Corp (SMED) in Q1 2022, closing a stake of 221,313 shares — an estimated $1.58M sold.

VanEck Associates first reported a position in SMED in Q2 2020 and held it in 7 quarters. The position peaked at $1.58M in Q4 2021. 80 funds tracked by Wall St. Rank hold SMED as of Q1 2022.

  • VanEck Associates reported no remaining Sharps Compliance Corp position as of Q1 2022 after selling out during the quarter.
  • VanEck Associates sold 221,313 Sharps Compliance Corp shares in Q1 2022, an estimated $1.58M.
  • VanEck Associates first reported a position in Sharps Compliance Corp in Q2 2020 and held it in 7 quarters.
  • VanEck Associates's Sharps Compliance Corp position peaked at $1.58M in Q4 2021.
  • 80 funds tracked by Wall St. Rank held Sharps Compliance Corp as of Q1 2022.

Based on VanEck Associates's 13F filing for Q1 2022, filed 10 May 2022.